G6U-61684-61382 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-23
Dose 1 — Pfizer-BioNTech
2021-04-13
Dose 2 — Pfizer-BioNTech
2021-11-05
Registered in v-safe
2021-11-05
Dose 3 — Pfizer-BioNTech
2021-11-05
Survey response — day 0, dose 3
MedDRA: Pregnancy — Feeling: Fair · Site: Redness · Muscle or body aches, Fatigue or tiredness, Nausea

Free text: I am 20 weeks pregnant

MedDRA releases: 2024-11 · check-in free text available
2021-11-08
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-11-09
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-11-21
Health check-in — day 14, dose 3
Feeling: Good

Adult check-in
2021-12-03
Health check-in — day 28, dose 3
Feeling: Good

Adult check-in
2022-11-05
Survey response — 12 months, dose 3
MedDRA: Fatigue — Feeling: Fair · Be unable to do your normal daily activities

Free text: Fatigue.

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-23	Pfizer-BioNTech	No
2	2021-04-13	Pfizer-BioNTech	No
3	2021-11-05	Pfizer-BioNTech	No

Free text

Release 10 — day 0, dose 3

2021-11-05

Systemic reaction (other): I am 20 weeks pregnant

Release 12 — 12 months, dose 3

2022-11-05

Symptoms: Fatigue.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Fatigue	·	·	✓
SRO	Pregnancy	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release